Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trialJia Liu, Luqi Huang, Cheng Lü et al.|Phytomedicine|2021Cited by 71
Efficacy and safety of Chinese herbal medicine versus Lopinavir-Ritonavir in adult patients with coronavirus disease 2019: A non-randomized controlled trialNannan Shi, Luqi Huang, Huaxin Shi et al.|Phytomedicine|2020Cited by 59